Last week, Johnson & Johnson issued a recall of 2.5 million packages of their Tylenol Cold Multi-Symptom Nighttime Rapid Release Gelcaps.

Officials issued the recall after investigators discovered unusually high levels of chlorpheniramine ammonio acetate in some of the capsules.  The company says they have not received reports of illness from the recalled product and that adverse risk associated with the product is very small.

The recall was issued for wholesale and retailers.  Packages already purchased by consumers before the date of the recall are said to be safe and can continue to be used.

If you or someone you love has become ill after taking a recalled or defective pharmaceutical product, contact the Denver pharmaceutical liability lawyers of Hull & Zimmerman, P.C. at 866-385-3505 to learn more about how we can help you.